Sutlu T - Search Results

1

Splice-correcting oligonucleotides restore BTK function in X-linked agammaglobulinemia model.

Bestas B, Moreno PM, Blomberg KE, Mohammad DK, Saleh AF, Sutlu T, Nordin JZ, Guterstam P, Gustafsson MO, Kharazi S, Piątosa B, Roberts TC, Behlke MA, Wood MJ, Gait MJ, Lundin KE, El Andaloussi S, Månsson R, Berglöf A, Wengel J, Smith CI. Bestas B, et al. Among authors: sutlu t. J Clin Invest. 2014 Sep;124(9):4067-81. doi: 10.1172/JCI76175. Epub 2014 Aug 8. J Clin Invest. 2014. PMID: 25105368 Free PMC article.

2

Delivery of short interfering RNA using endosomolytic cell-penetrating peptides.

Lundberg P, El-Andaloussi S, Sütlü T, Johansson H, Langel U. Lundberg P, et al. Among authors: sutlu t. FASEB J. 2007 Sep;21(11):2664-71. doi: 10.1096/fj.06-6502com. Epub 2007 Apr 26. FASEB J. 2007. PMID: 17463227

3

Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model.

Alici E, Konstantinidis KV, Sutlu T, Aints A, Gahrton G, Ljunggren HG, Dilber MS. Alici E, et al. Among authors: sutlu t. Exp Hematol. 2007 Dec;35(12):1839-46. doi: 10.1016/j.exphem.2007.08.006. Exp Hematol. 2007. PMID: 18036444 Free article.

4

Retroviral gene transfer into primary human natural killer cells.

Alici E, Sutlu T, Sirac Dilber M. Alici E, et al. Among authors: sutlu t. Methods Mol Biol. 2009;506:127-37. doi: 10.1007/978-1-59745-409-4_10. Methods Mol Biol. 2009. PMID: 19110624

5

Inhibition of intracellular antiviral defense mechanisms augments lentiviral transduction of human natural killer cells: implications for gene therapy.

Sutlu T, Nyström S, Gilljam M, Stellan B, Applequist SE, Alici E. Sutlu T, et al. Hum Gene Ther. 2012 Oct;23(10):1090-100. doi: 10.1089/hum.2012.080. Epub 2012 Sep 10. Hum Gene Ther. 2012. PMID: 22779406 Free PMC article.

6

Suicide gene therapy for graft-versus-host disease.

Georgoudaki AM, Sutlu T, Alici E. Georgoudaki AM, et al. Among authors: sutlu t. Immunotherapy. 2010 Jul;2(4):521-37. doi: 10.2217/imt.10.19. Immunotherapy. 2010. PMID: 20636006 Review.

7

Natural killer cell-based immunotherapy in cancer: current insights and future prospects.

Sutlu T, Alici E. Sutlu T, et al. J Intern Med. 2009 Aug;266(2):154-81. doi: 10.1111/j.1365-2796.2009.02121.x. J Intern Med. 2009. PMID: 19614820 Free article. Review.

8

Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components.

Alici E, Sutlu T, Björkstrand B, Gilljam M, Stellan B, Nahi H, Quezada HC, Gahrton G, Ljunggren HG, Dilber MS. Alici E, et al. Among authors: sutlu t. Blood. 2008 Mar 15;111(6):3155-62. doi: 10.1182/blood-2007-09-110312. Epub 2008 Jan 11. Blood. 2008. PMID: 18192509 Free article.

9

Clinical impact of chromosomal aberrations in multiple myeloma.

Nahi H, Sutlu T, Jansson M, Alici E, Gahrton G. Nahi H, et al. Among authors: sutlu t. J Intern Med. 2011 Feb;269(2):137-47. doi: 10.1111/j.1365-2796.2010.02324.x. Epub 2010 Dec 15. J Intern Med. 2011. PMID: 21158983 Free article. Review.

10

Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D.

Sayitoglu EC, Georgoudaki AM, Chrobok M, Ozkazanc D, Josey BJ, Arif M, Kusser K, Hartman M, Chinn TM, Potens R, Pamukcu C, Krueger R, Zhang C, Mardinoglu A, Alici E, Temple HT, Sutlu T, Duru AD. Sayitoglu EC, et al. Among authors: sutlu t. Front Immunol. 2020 Jan 28;11:40. doi: 10.3389/fimmu.2020.00040. eCollection 2020. Front Immunol. 2020. PMID: 32082316 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page